Loading company…
PhotoSonix Medical develops CLENS, an investigational non-drug device for treating moderate to severe acne, based in Ambler, US.
Founded in 2014 and headquartered in Ambler, US, PhotoSonix Medical develops its investigational CLENS device, a non-drug acne treatment sold mainly to healthcare providers and dermatologists in North America. The company raised USD 1.4 mn in Seed funding from Princeton BioPharma Capital Partners on January 26, 2016. It plans to use the funds for new device development and to expand into Europe and Asia by 2025.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign inWork at PhotoSonix Medical, Inc.? This is my company